Type 1 Diabetes

HOUSTON — A retrospective chart review of adults with type 1 diabetes who used the Medtronic MiniMed 670G revealed generally favorable experiences with the technology as well as improvements in HbA1c, according to findings presented at the American Association of Diabetes Educators annual meeting.

HOUSTON — In this video exclusive, Tracey D. Brown, CEO of the American Diabetes Association, speaks with Diabetes in Real Life columnist Susan Weiner, MS, RDN, CDE, FAADE, about the ADA’s role in diabetes education.

HOUSTON — “Diabetes care and education specialists” is the new name the American Association of Diabetes Educators unveiled for members. The new designation is designed to better reflect the role of educators as “the cornerstone of the diabetes care team,” according to a speaker here.

HOUSTON — Beyond individuals, social, geographic and economic factors influence the risk for developing diabetes. By identifying specific factors on the local level, researchers are developing interventions to head off disease, according to two presenters at the American Association of Diabetes Educators annual meeting.

Adolescents and young adults with type 1 diabetes who took part in a diabetes education course that was specifically designed for their age group achieved lower HbA1c and had increased confidence in their ability to manage their disease, according to findings published in Diabetic Medicine.

Itemizing positive aspects of life, or “gratitude journaling,” may help adolescents with type 1 diabetes achieve reduced HbA1c levels, according to findings published in Diabetic Medicine.

The Parker Institute for Cancer Immunotherapy, in collaboration with the Juvenile Diabetes Research Foundation and Helmsley Charitable Trust, have formed a cancer and diabetes research initiative to better understand the association between immunotherapy treatment and subsequent risk for type 1 diabetes.

Children with type 1 diabetes are no more likely to have autism spectrum disorder than children without the condition, although those with autism spectrum disorder may display some superior diabetes management outcomes, according to findings published in Diabetic Medicine.

A C-peptide level of more than 20 pmol/L may indicate a lower risk for hypoglycemia among adults with type 1 diabetes, suggesting that these individuals may safely pursue tighter glycemic targets, according to findings published in Diabetic Medicine.

Insulin secretion is a process in the human body that primarily occurs in response to glucose levels in the blood becoming elevated. However, although the process is not fully understood, research has demonstrated that several steps occur in a predictable fashion. For example, it is known that insulin facilitates the entry of glucose into cells. Stimulants for insulin secretion can range from seeing, smelling or tasting food to increases in fuel molecules in the blood. Those fuel molecules include amino and fatty acids.